Identification of Genes Linked to Gefitinib Treatment in Prostate Cancer Cell Lines With or Without Resistance to Androgen: A Clue to Application of Gefitinib to Hormone-Resistant Prostate Cancer

Oncology Reports - Greece
doi 10.3892/or.15.6.1453
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation

Asian Journal of Andrology
MedicineUrology
2013English

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-Small Cell Lung Cancer Cell Lines

Journal of Cancer
Oncology
2020English

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Treatment of Hormone‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Identification of Prostate Cancer-Related Genes Using Inhibition of NMD in Prostate Cancer Cell Lines

2007English

Leukoerythroblastosis in Castration-Resistant Prostate Cancer: A Clue to Diffuse Bone Marrow Carcinomatosis

Clinics and Practice
2019English

The Diverse and Contrasting Effects of Using Human Prostate Cancer Cell Lines to Study Androgen Receptor Roles in Prostate Cancer

Asian Journal of Andrology
MedicineUrology
2008English

Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

PLoS ONE
Multidisciplinary
2013English

Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy